Wen Ling

1.6k total citations
45 papers, 1.2k citations indexed

About

Wen Ling is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Wen Ling has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 19 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Wen Ling's work include Multiple Myeloma Research and Treatments (25 papers), Bone health and treatments (12 papers) and Peptidase Inhibition and Analysis (6 papers). Wen Ling is often cited by papers focused on Multiple Myeloma Research and Treatments (25 papers), Bone health and treatments (12 papers) and Peptidase Inhibition and Analysis (6 papers). Wen Ling collaborates with scholars based in United States, China and Italy. Wen Ling's co-authors include Shmuel Yaccoby, Bart Barlogie, John D. Shaughnessy, Ronald C. Walker, Sharmin Khan, Xin Li, Fenghuang Zhan, Angela Pennisi, Maurizio Zangari and Joshua Epstein and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Wen Ling

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Ling United States 15 589 579 520 150 113 45 1.2k
Adelheid Korb Germany 8 482 0.8× 950 1.6× 240 0.5× 119 0.8× 198 1.8× 9 2.0k
Sebastian Stier Germany 13 382 0.6× 680 1.2× 665 1.3× 346 2.3× 136 1.2× 21 1.5k
Christine Huard United States 13 302 0.5× 648 1.1× 390 0.8× 104 0.7× 108 1.0× 16 1.4k
Stephanie Lefèvre Germany 10 238 0.4× 453 0.8× 169 0.3× 64 0.4× 179 1.6× 11 1.2k
Simona Berardi Italy 18 321 0.5× 423 0.7× 331 0.6× 71 0.5× 121 1.1× 37 970
Nisha Nanda United States 14 235 0.4× 286 0.5× 444 0.9× 213 1.4× 101 0.9× 33 1.4k
Colleen Wu United States 12 469 0.8× 675 1.2× 114 0.2× 129 0.9× 535 4.7× 19 1.3k
Joseph A. Lorenzo United States 21 642 1.1× 906 1.6× 118 0.2× 96 0.6× 127 1.1× 31 1.4k
Mohammad Shahjahani Iran 19 247 0.4× 580 1.0× 463 0.9× 350 2.3× 267 2.4× 67 1.3k
F Viguié France 21 302 0.5× 861 1.5× 844 1.6× 273 1.8× 206 1.8× 45 1.6k

Countries citing papers authored by Wen Ling

Since Specialization
Citations

This map shows the geographic impact of Wen Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Ling more than expected).

Fields of papers citing papers by Wen Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Ling. The network helps show where Wen Ling may publish in the future.

Co-authorship network of co-authors of Wen Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Ling. A scholar is included among the top collaborators of Wen Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Ling. Wen Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richardson, Kimberly, Gareeballah Osman Adam, Wen Ling, et al.. (2024). Mitochondrial protein deacetylation by SIRT3 in osteoclasts promotes bone resorption with aging in female mice. Molecular Metabolism. 88. 102012–102012. 6 indexed citations
2.
Ling, Wen. (2024). Virtual Reality-based Meta-Cosmic Perspective on Curriculum Integration Innovations in Art and Technology Programs. Applied Mathematics and Nonlinear Sciences. 9(1). 1 indexed citations
3.
Chen, Sida, Wen Ling, Yumei Wu, et al.. (2024). Circular RNA circ-CARD8 regulates alveolar macrophage pyroptosis through the miR-580-3p/CARD8 pathway in acute lung injury. PLoS ONE. 19(12). e0314936–e0314936.
4.
Ling, Wen, Sadie Johnson, Syed J. Mehdi, et al.. (2023). EDNRA-Expressing Mesenchymal Cells Are Expanded in Myeloma Interstitial Bone Marrow and Associated with Disease Progression. Cancers. 15(18). 4519–4519. 4 indexed citations
5.
Mehdi, Syed J., Kalyan Ghatak, Wen Ling, et al.. (2023). Growth and dormancy control of myeloma cells by mesenchymal stem cells. Leukemia Research. 133. 107355–107355. 3 indexed citations
6.
Richardson, Kimberly, Wen Ling, Kimberly J. Krager, et al.. (2022). Ionizing Radiation Activates Mitochondrial Function in Osteoclasts and Causes Bone Loss in Young Adult Male Mice. International Journal of Molecular Sciences. 23(2). 675–675. 19 indexed citations
7.
Wang, Xiaoyan, Lijian Shao, Kimberly Richardson, et al.. (2022). Hematopoietic cytoplasmic adaptor protein Hem1 promotes osteoclast fusion and bone resorption in mice. Journal of Biological Chemistry. 299(2). 102841–102841. 5 indexed citations
8.
Schinke, Carolina, Jordan T. Bird, Pingping Qu, et al.. (2021). PHF19 inhibition as a therapeutic target in multiple myeloma. Current Research in Translational Medicine. 69(3). 103290–103290. 3 indexed citations
9.
Ling, Wen, Kimberly J. Krager, Kimberly Richardson, et al.. (2021). Mitochondrial Sirt3 contributes to the bone loss caused by aging or estrogen deficiency. JCI Insight. 6(10). 69 indexed citations
10.
Bam, Rakesh, Sharmin Khan, Wen Ling, et al.. (2015). Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow. BMC Cancer. 15(1). 864–864. 14 indexed citations
11.
Bam, Rakesh, Sathisha Upparahalli Venkateshaiah, Salma Khan, et al.. (2014). Role of Bruton’s tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cells. Blood Cancer Journal. 4(8). e234–e234. 9 indexed citations
12.
Venkateshaiah, Sathisha Upparahalli, Sharmin Khan, Wen Ling, et al.. (2013). NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity. Experimental Hematology. 41(6). 547–557.e2. 45 indexed citations
13.
Venkateshaiah, Sathisha Upparahalli, Rakesh Bam, Xin Li, et al.. (2013). GPRC5D Is a Cell Surface Plasma Cell Marker Whose Expression Is High In Myeloma Cells and Reduced Following Coculture With Osteoclasts. Blood. 122(21). 3099–3099. 8 indexed citations
14.
Yi, Lan, Hui Tan, Min Lin, et al.. (2010). Role of Ras‐related C3 botulinum toxin substrate 2 (Rac2), NADPH oxidase and reactive oxygen species in diallyl disulphide‐induced apoptosis of human leukaemia HL‐60 cells. Clinical and Experimental Pharmacology and Physiology. 37(12). 1147–1153. 16 indexed citations
15.
Pennisi, Angela, Wen Ling, Xin Li, et al.. (2010). Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous Bone. PLoS ONE. 5(12). e15233–e15233. 35 indexed citations
16.
Li, Xin, Wen Ling, Angela Pennisi, Sharmin Khan, & Shmuel Yaccoby. (2009). Fenretinide inhibits myeloma cell growth, osteoclastogenesis and osteoclast viability. Cancer Letters. 284(2). 175–181. 14 indexed citations
17.
Pennisi, Angela, Xin Li, Wen Ling, et al.. (2009). Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease. British Journal of Haematology. 145(6). 775–787. 22 indexed citations
18.
Pennisi, Angela, Xin Li, Wen Ling, et al.. (2008). The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo. American Journal of Hematology. 84(1). 6–14. 110 indexed citations
19.
Anaissie, Elias, Weizhi Zhao, Monica Grazziutti, et al.. (2008). Deficiency of Mannose-Binding Lectin Is a Risk Factor for Invasive Pulmonary Aspergillosis in Patients with Multiple Myeloma: An Analysis of 482 Patients. Blood. 112(11). 667–667. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adelheid Korb Breakdown of academic impact, for papers by Sebastian Stier Breakdown of academic impact, for papers by Christine Huard Breakdown of academic impact, for papers by Stephanie Lefèvre Breakdown of academic impact, for papers by Simona Berardi Breakdown of academic impact, for papers by Nisha Nanda Breakdown of academic impact, for papers by Colleen Wu Breakdown of academic impact, for papers by Joseph A. Lorenzo Breakdown of academic impact, for papers by Mohammad Shahjahani Breakdown of academic impact, for papers by F Viguié
Rankless by CCL
2026